iScience (Oct 2023)

A modular phage vector platform for targeted photodynamic therapy of Gram-negative bacterial pathogens

  • Annapaola Petrosino,
  • Roberto Saporetti,
  • Francesco Starinieri,
  • Edoardo Sarti,
  • Luca Ulfo,
  • Luca Boselli,
  • Andrea Cantelli,
  • Andrea Morini,
  • Suleman Khan Zadran,
  • Giampaolo Zuccheri,
  • Zeno Pasquini,
  • Matteo Di Giosia,
  • Luca Prodi,
  • Pier Paolo Pompa,
  • Paolo Emidio Costantini,
  • Matteo Calvaresi,
  • Alberto Danielli

Journal volume & issue
Vol. 26, no. 10
p. 108032

Abstract

Read online

Summary: Growing antibiotic resistance has encouraged the revival of phage-inspired antimicrobial approaches. On the other hand, photodynamic therapy (PDT) is considered a very promising research domain for the protection against infectious diseases. Yet, very few efforts have been made to combine the advantages of both approaches in a modular, retargetable platform. Here, we foster the M13 bacteriophage as a multifunctional scaffold, enabling the selective photodynamic killing of bacteria. We took advantage of the well-defined molecular biology of M13 to functionalize its capsid with hundreds of photo-activable Rose Bengal sensitizers and contemporarily target this light-triggerable nanobot to specific bacterial species by phage display of peptide targeting moieties fused to the minor coat protein pIII of the phage. Upon light irradiation of the specimen, the targeted killing of diverse Gram(−) pathogens occurred at subnanomolar concentrations of the phage vector. Our findings contribute to the development of antimicrobials based on targeted and triggerable phage-based nanobiotherapeutics.

Keywords